OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of Microbiota-Gut-Brain Axis by Berberine Resulting in Improved Metabolic Status in High-Fat Diet-Fed Rats
Honglin Sun, Ningjian Wang, Zhen Cang, et al.
Obesity Facts (2016) Vol. 9, Iss. 6, pp. 365-378
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
Xiaojun Feng, Antoni Sureda, Samineh Jafari, et al.
Theranostics (2019) Vol. 9, Iss. 7, pp. 1923-1951
Open Access | Times Cited: 322

Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology
Jin Wang, Lin Wang, Guanhua Lou, et al.
Pharmaceutical Biology (2019) Vol. 57, Iss. 1, pp. 193-225
Open Access | Times Cited: 312

Berberine pharmacology and the gut microbiota: A hidden therapeutic link
Solomon Habtemariam
Pharmacological Research (2020) Vol. 155, pp. 104722-104722
Closed Access | Times Cited: 235

Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence
Xinmei Xu, Huan Yi, Jiasi Wu, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110984-110984
Open Access | Times Cited: 158

Abnormal gut microbiota composition contributes to cognitive dysfunction in SAMP8 mice
Gaofeng Zhan, Ning Yang, Shan Li, et al.
Aging (2018) Vol. 10, Iss. 6, pp. 1257-1267
Open Access | Times Cited: 152

A polysaccharide extracted from Astragalus membranaceus residue improves cognitive dysfunction by altering gut microbiota in diabetic mice
Yameng Liu, Wei Liu, Jing Li, et al.
Carbohydrate Polymers (2018) Vol. 205, pp. 500-512
Closed Access | Times Cited: 115

Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota
Haiyu Zhang, Jiaxing Tian, Fengmei Lian, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110857-110857
Open Access | Times Cited: 106

Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine
Hao Cheng, Juan Liu, Yuzhu Tan, et al.
Journal of Pharmaceutical Analysis (2021) Vol. 12, Iss. 4, pp. 541-555
Open Access | Times Cited: 93

The effect of Berberine on weight loss in order to prevent obesity: A systematic review
Zahra Ilyas, Simone Perna, Salwa Al-Thawadi, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 127, pp. 110137-110137
Open Access | Times Cited: 91

Citrus peel extracts attenuated obesity and modulated gut microbiota in mice with high-fat diet-induced obesity
Yen‐Chen Tung, Wei‐Tien Chang, Shiming Li, et al.
Food & Function (2018) Vol. 9, Iss. 6, pp. 3363-3373
Closed Access | Times Cited: 86

Abnormal gut microbiota composition contributes to the development of type 2 diabetes mellitus in db/db mice
Yu Fan, Wei Han, Gaofeng Zhan, et al.
Aging (2019) Vol. 11, Iss. 22, pp. 10454-10467
Open Access | Times Cited: 86

Inhibition effect of glycyrrhiza polysaccharide (GCP) on tumor growth through regulation of the gut microbiota composition
Xiaoyu Zhang, Shuwu Zhao, Xinbo Song, et al.
Journal of Pharmacological Sciences (2018) Vol. 137, Iss. 4, pp. 324-332
Open Access | Times Cited: 84

Effects of Berberine on the Gastrointestinal Microbiota
Lichao Zhang, Xiaoying Wu, Ruibing Yang, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 10
Open Access | Times Cited: 73

Berberine alleviates lipid metabolism disorders via inhibition of mitochondrial complex I in gut and liver
Muyu Yu, Miriayi Alimujiang, Lili Hu, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 7, pp. 1693-1707
Open Access | Times Cited: 62

Gut microbiota-SCFAs-brain axis associated with the antidepressant activity of berberine in CUMS rats
Mengnan Huang, Yuanyuan He, Lin Tian, et al.
Journal of Affective Disorders (2023) Vol. 325, pp. 141-150
Closed Access | Times Cited: 28

Gut Microbiota and Bone Health
Darin Quach, Robert A. Britton
Advances in experimental medicine and biology (2017), pp. 47-58
Closed Access | Times Cited: 84

Abnormal composition of gut microbiota contributes to delirium‐like behaviors after abdominal surgery in mice
Jie Zhang, Jiang‐Jiang Bi, Guo‐Jun Guo, et al.
CNS Neuroscience & Therapeutics (2019) Vol. 25, Iss. 6, pp. 685-696
Open Access | Times Cited: 75

Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
Li Zhao, Zhen Cang, Honglin Sun, et al.
BMC Endocrine Disorders (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 72

Hypoglycemic Mechanism of the Berberine Organic Acid Salt under the Synergistic Effect of Intestinal Flora and Oxidative Stress
Hong‐Xin Cui, Yanan Hu, Jingwan Li, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 67

Antiobesity Effect of Flaxseed Polysaccharide via Inducing Satiety due to Leptin Resistance Removal and Promoting Lipid Metabolism through the AMP-Activated Protein Kinase (AMPK) Signaling Pathway
Jianming Luo, Jiamei Qi, Wenjun Wang, et al.
Journal of Agricultural and Food Chemistry (2019) Vol. 67, Iss. 25, pp. 7040-7049
Closed Access | Times Cited: 65

Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders
Weijia Kong, Claudio Vernieri, Marco Foiani, et al.
Pharmacology & Therapeutics (2020) Vol. 209, pp. 107496-107496
Closed Access | Times Cited: 62

Abnormal gut microbiota composition contributes to cognitive dysfunction in streptozotocin-induced diabetic mice
Yu Fan, Wei Han, Gaofeng Zhan, et al.
Aging (2019) Vol. 11, Iss. 10, pp. 3262-3279
Open Access | Times Cited: 54

Gut Microbiota Associations with Metabolic Health and Obesity Status in Older Adults
Xiaozhong Zhong, J M Harrington, Seán Millar, et al.
Nutrients (2020) Vol. 12, Iss. 8, pp. 2364-2364
Open Access | Times Cited: 51

The rich pharmacological activities of Magnolia officinalis and secondary effects based on significant intestinal contributions
Lin Niu, Yuanyuan Hou, Min Jiang, et al.
Journal of Ethnopharmacology (2021) Vol. 281, pp. 114524-114524
Closed Access | Times Cited: 47

The mechanism of berberine alleviating metabolic disorder based on gut microbiome
Han Wang, Haiyu Zhang, Zezheng Gao, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 33

Page 1 - Next Page

Scroll to top